Systemic Immunotherapy for the Treatment of Brain Metastases

被引：60

作者：

Cohen, Justine V. ^{[1
]}

Kluger, Harriet M. ^{[1
]}

机构：

[1] Yale Canc Ctr, Dept Med, Sect Med Oncol, New Haven, CT USA

来源：

FRONTIERS IN ONCOLOGY | 2016年 / 6卷

关键词：

immunotherapy; brain metastases; melanoma; CENTRAL NERVOUS-SYSTEM; MELANOMA PATIENTS; ANTI-PD-L1; ANTIBODY; CLINICAL ACTIVITY; OPEN-LABEL; CHECKPOINT BLOCKADE; RADIATION-THERAPY; IPILIMUMAB; SAFETY; EFFICACY;

D O I：

10.3389/fonc.2016.00049

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 58 条

[1] Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study [J].

Agarwala, SS ;

Kirkwood, JM ;

Gore, M ;

Dreno, B ;

Thatcher, N ;

Czarnetski, B ;

Atkins, M ;

Buzaid, A ;

Skarlos, D ;

Rankin, EM .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2101-2107

[2]

[Anonymous], ASCO M S

[3] Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma:: A phase III study [J].

Avril, MF ;

Aamdal, S ;

Grob, JJ ;

Hauschild, A ;

Mohr, P ;

Bonerandi, JJ ;

Weichenthal, M ;

Neuber, K ;

Bieber, T ;

Gilde, K ;

Porta, VG ;

Fra, J ;

Bonneterre, J ;

Saïag, P ;

Kamanabrou, D ;

Pehamberger, H ;

Sufliarsky, J ;

Larriba, JLG ;

Scherrer, A ;

Menu, Y .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1118-1125

[4] The Effectiveness of Erlotinib Against Brain Metastases in Non-Small Cell Lung Cancer Patients [J].

Bai, Hao ;

Han, Baohui .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (02) :110-115

[5]

Brahmer JR, 2014, J CLIN ONCOL, V32, P8021, DOI DOI 10.1200/jco.2014.32.15_suppl.8021

[6] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[7]

Brown PD, 2015, ASCO M S, V33, pLBA4

[8] Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases? [J].

Colaco, Rovel J. ;

Martin, Pierre ;

Kluger, Harriet M. ;

Yu, James B. ;

Chiang, Veronica L. .

JOURNAL OF NEUROSURGERY, 2016, 125 (01) :17-23

[9] Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer [J].

De Braganca, Kevin C. ;

Janjigian, Yelena Y. ;

Azzoli, Christopher G. ;

Kris, Mark G. ;

Pietanza, Maria C. ;

Nolan, Craig P. ;

Omuro, Antonio M. ;

Holodny, Andrei I. ;

Lassman, Andrew B. .

JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (03) :443-447

[10] Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study [J].

Di Giacomo, A. M. ;

Ascierto, P. A. ;

Queirolo, P. ;

Pilla, L. ;

Ridolfi, R. ;

Santinami, M. ;

Testori, A. ;

Simeone, E. ;

Guidoboni, M. ;

Maurichi, A. ;

Orgiano, L. ;

Spadola, G. ;

Del Vecchio, M. ;

Danielli, R. ;

Calabro, L. ;

Annesi, D. ;

Giannarelli, D. ;

Maccalli, C. ;

Fonsatti, E. ;

Parmiani, G. ;

Maio, M. .

ANNALS OF ONCOLOGY, 2015, 26 (04) :798-803

← 1 2 3 4 5 6 →